SGK3 and breast carcinoma: It was also reported that inhibition of SGK3, a downstream kinase of ERα in breast cancer, could drastically suppress aromatase inhibitors (AI)-resistant tumor cell survival via inducing intense ER stress (Wang et al., 2017).